Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01578018 · ClinicalTrials.gov registry record · NA

Tumor Markers in Lung Cancer: DCAMLK-1LK-1

A NA study of Lung Cancer and Smoking, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
49
Enrollment target
1
Study location

NCT01578018 is a NA study of Lung Cancer and Smoking that has completed, run by University of Oklahoma. The registered enrollment target is 49 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01578018, a NA study of Lung Cancer and Smoking, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target
1
Study location

Study Summary

DCAMLK1 is a Ca2+ - ca/modulin (CaM) - dependent protein kinase that is a marker of stem cells in colonic crypts. Mutations within the stem cell population are thought to be responsible for the development of most colorectal carcinomas and studies have shown that DCAMLK1 is highly expressed in these tumors. Since the lung is an embryological development of the foregut, the investigators speculate that DCAMLK1 will also be upregulated in lung cancers. The aim of this pilot study is to measure DCAMLK1 levels in the blood of patients with suspected malignant and benign lung diseases, and to correlate DCAMKL1 levels with smoking status.

Conditions Studied

Lung Cancer Smoking

Interventions

  • OTHER Measure DCAM levels in blood
  • OTHER DCAM levels in blood

Study Locations (1)

Oklahoma

  • VAMC-OKC - Oklahoma City

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2011-12
Est. Completion 2012-07
Phase NA

Sponsor

University of Oklahoma

358 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01578018

The ClinicalTrials.gov registry entry for NCT01578018 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Measure DCAM levels in blood is the first listed.

NCT01578018 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT01578018 about?

NCT01578018 is a clinical study titled "Tumor Markers in Lung Cancer: DCAMLK-1LK-1". DCAMLK1 is a Ca2+ - ca/modulin (CaM) - dependent protein kinase that is a marker of stem cells in colonic crypts. Mutations within the stem cell population are thought to be responsible for the development of most colorectal carcinomas and studies have shown that DCAMLK1 is highly expressed in these...

What is the current status of trial NCT01578018?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2011-12. Estimated completion is 2012-07.

What conditions does trial NCT01578018 study?

This clinical trial studies the following conditions: Lung Cancer, Smoking.

What interventions are being tested in trial NCT01578018?

The interventions under investigation include: Measure DCAM levels in blood (OTHER), DCAM levels in blood (OTHER).

Who is sponsoring clinical trial NCT01578018?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01578018 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Smoking

All registered trials for this condition

Oklahoma

All trials with a study site in Oklahoma

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.